Literature DB >> 20225204

Distribution analysis of deacetylase SIRT1 in rodent and human nervous systems.

Sherry M Zakhary1, Diana Ayubcha, Jeffery N Dileo, Riya Jose, Joerg R Leheste, Judith M Horowitz, German Torres.   

Abstract

Sirtuins function with other biogenic molecules to promote adaptation to caloric restriction in a broad spectrum of eukaryotic species. Sirtuin pathways also converge in the mammalian brain where they appear to protect neurons from nutrient stress. However, few anatomical studies on sirtuins (e.g., SIRT1) are available, particularly those detailing the spatial distribution and subcellular localization pattern of SIRT1 in the brain parenchyma. Here, we report the characterization of a panel of SIRT1-specific antibodies within rodent (i.e., rat and mouse) and human central nervous systems. Immunocytochemical and Western blot analyses indicate that the subcellular localization of SIRT1 is predominantly nuclear throughout the rodent brain and spinal cord. A similar subcellular distribution pattern of SIRT1 was detected in human central nervous system material. SIRT1 is ubiquitously present in areas of the brain especially susceptible to age-related neurodegenerative states (e.g., the prefrontal cortex, hippocampus and basal ganglia). Further, we show no apparent species-specific differences in the subcellular localization pattern of rodent versus human SIRT1. Finally, we identify the chemical phenotype of SIRT1-containing neurons in a number of brain sites that are strongly compromised by aging. These data provide additional and important anatomical findings for the role of SIRT1 in the mammalian brain and suggest that SIRT1 pathways are broadly distributed in neurons most susceptible to senescence injury. Activating endogenous sirtuin pathways may, therefore, offer a therapeutic approach to delay and/or treat human age-related diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20225204      PMCID: PMC3071026          DOI: 10.1002/ar.21116

Source DB:  PubMed          Journal:  Anat Rec (Hoboken)        ISSN: 1932-8486            Impact factor:   2.064


  23 in total

1.  A simple and sensitive antigen retrieval method for free-floating and slide-mounted tissue sections.

Authors:  Y Jiao; Z Sun; T Lee; F R Fusco; T D Kimble; C A Meade; S Cuthbertson; A Reiner
Journal:  J Neurosci Methods       Date:  1999-11-15       Impact factor: 2.390

2.  Characterization of fluoxetine plus olanzapine treatment in rats: a behavior, endocrine, and immediate-early gene expression analysis.

Authors:  Judith M Horowitz; Alpna Goyal; Navindra Ramdeen; Brian H Hallas; A Thomas Horowitz; German Torres
Journal:  Synapse       Date:  2003-12-15       Impact factor: 2.562

3.  Immunocytochemical and in situ hybridization detection of hypothalamic neuropeptides from postmortem unfixed rat brains.

Authors:  G Torres; S Lee; C Rivier
Journal:  Neurosci Lett       Date:  1992-10-26       Impact factor: 3.046

4.  Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction.

Authors:  Weiping Qin; Tianle Yang; Lap Ho; Zhong Zhao; Jun Wang; Linghong Chen; Wei Zhao; Meenakshisundaram Thiyagarajan; Donal MacGrogan; Joseph T Rodgers; Pere Puigserver; Junichi Sadoshima; Haiteng Deng; Steven Pedrini; Samuel Gandy; Anthony A Sauve; Giulio M Pasinetti
Journal:  J Biol Chem       Date:  2006-06-02       Impact factor: 5.157

5.  Ventricular size mapping in a transgenic model of schizophrenia.

Authors:  German Torres; Beth A Meeder; Brian H Hallas; Joseph A Spernyak; Richard Mazurchuk; Craig Jones; Kenneth W Gross; Judith M Horowitz
Journal:  Brain Res Dev Brain Res       Date:  2005-01-01

Review 6.  Parkinson's disease: mechanisms and models.

Authors:  William Dauer; Serge Przedborski
Journal:  Neuron       Date:  2003-09-11       Impact factor: 17.173

7.  A neurobehavioral screening of the ckr mouse mutant: implications for an animal model of schizophrenia.

Authors:  German Torres; Brian H Hallas; Vita A Vernace; Craig Jones; Kenneth W Gross; Judith M Horowitz
Journal:  Brain Res Bull       Date:  2004-01-15       Impact factor: 4.077

8.  Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase.

Authors:  Fan Yeung; Jamie E Hoberg; Catherine S Ramsey; Michael D Keller; David R Jones; Roy A Frye; Marty W Mayo
Journal:  EMBO J       Date:  2004-05-20       Impact factor: 11.598

Review 9.  Toxic proteins in neurodegenerative disease.

Authors:  J Paul Taylor; John Hardy; Kenneth H Fischbeck
Journal:  Science       Date:  2002-06-14       Impact factor: 47.728

10.  Mammalian SIRT1 represses forkhead transcription factors.

Authors:  Maria Carla Motta; Nullin Divecha; Madeleine Lemieux; Christopher Kamel; Delin Chen; Wei Gu; Yvette Bultsma; Michael McBurney; Leonard Guarente
Journal:  Cell       Date:  2004-02-20       Impact factor: 41.582

View more
  42 in total

Review 1.  Epigenetic protein families: a new frontier for drug discovery.

Authors:  Cheryl H Arrowsmith; Chas Bountra; Paul V Fish; Kevin Lee; Matthieu Schapira
Journal:  Nat Rev Drug Discov       Date:  2012-04-13       Impact factor: 84.694

2.  Targeting sirtuins for the treatment of diabetes.

Authors:  Frank K Huynh; Kathleen A Hershberger; Matthew D Hirschey
Journal:  Diabetes Manag (Lond)       Date:  2013-05-01

3.  A behavioral and molecular analysis of ketamine in zebrafish.

Authors:  Sherry M Zakhary; Diana Ayubcha; Farah Ansari; Kiran Kamran; Mehwish Karim; Joerg R Leheste; Judith M Horowitz; German Torres
Journal:  Synapse       Date:  2011-02       Impact factor: 2.562

Review 4.  Sirtuin 1 and sirtuin 3: physiological modulators of metabolism.

Authors:  Ruben Nogueiras; Kirk M Habegger; Nilika Chaudhary; Brian Finan; Alexander S Banks; Marcelo O Dietrich; Tamas L Horvath; David A Sinclair; Paul T Pfluger; Matthias H Tschöp
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

5.  SIRT1 and SIRT7 expression in adipose tissues of obese and normal-weight individuals is regulated by microRNAs but not by methylation status.

Authors:  A Kurylowicz; M Owczarz; J Polosak; M I Jonas; W Lisik; M Jonas; A Chmura; M Puzianowska-Kuznicka
Journal:  Int J Obes (Lond)       Date:  2016-08-02       Impact factor: 5.095

Review 6.  SIRT1 and Neural Cell Fate Determination.

Authors:  Yulong Cai; Le Xu; Haiwei Xu; Xiaotang Fan
Journal:  Mol Neurobiol       Date:  2015-04-08       Impact factor: 5.590

7.  Sirtuin 5 is Anti-apoptotic and Anti-oxidative in Cultured SH-EP Neuroblastoma Cells.

Authors:  Fengyi Liang; Xie Wang; Suet Hui Ow; Wangxue Chen; Wei Chen Ong
Journal:  Neurotox Res       Date:  2016-08-30       Impact factor: 3.911

Review 8.  Could Sirtuin Activities Modify ALS Onset and Progression?

Authors:  Bor Luen Tang
Journal:  Cell Mol Neurobiol       Date:  2016-12-10       Impact factor: 5.046

Review 9.  Brain activation of SIRT1: role in neuropathology.

Authors:  Alanna Fernandes Paraíso; Keila Lopes Mendes; Sergio Henrique Sousa Santos
Journal:  Mol Neurobiol       Date:  2013-04-25       Impact factor: 5.590

10.  Age-related alterations in histone deacetylase expression in Purkinje neurons of ethanol-fed rats.

Authors:  Abhilasha Khurana; Cynthia A Dlugos
Journal:  Brain Res       Date:  2017-08-30       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.